Amgen Announces Award for Science Teaching Excellence in Rhode Island
FOR IMMEDIATE RELEASE
West Greenwich, Rhode Island, January 24, 2003 - Amgen (NASDAQ:AMGN) announced today it is launching the Amgen Award for Science Teaching Excellence in Rhode Island, its recognition program for science education. Two K-12 educators who work in either public or private schools in the state each will receive an unrestricted $10,000 award from Amgen, and will be honored at an award dinner in June.
For 11 years, Amgen has conducted the Amgen Award for Teacher Excellence. Last year, Amgen modified the award to focus solely on excellence in science teaching. This is the first year the Amgen Award for Science Teaching Excellence has been directed toward teachers in Rhode Island. Amgen also conducts similar programs in California; Colorado; Louisville, Kentucky; Puerto Rico; and Seattle.
Anyone can nominate an educator who teaches science. The nomination letter should include: the full name of the teacher; the name and address of the school; the name of the school district; the school's phone number; the grade level the science teacher teaches; the nominator's relationship to the science teacher; the nominator's phone number; and a description of why the science teacher deserves the award. The letter should describe the teacher's attributes in the areas of creativity, teaching effectiveness, best practice development, and instructional and motivational ability.
Letters should be sent to: Amgen's Award for Science Teaching Excellence, Amgen Inc., Larry Bernard, 40 Technology Way, M/S TS-A1, West Greenwich, RI, 02817. Nominations can also be submitted electronically, at www.Amgen.com/corporate/AmgenTeacher/index.html. Nominations for the award will be accepted immediately, through March 21, 2003.
Amgen is a global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology.
Barbara Bronson Gray: 805/447-4949
Amgen, Corporate Communications
EDITOR'S NOTES: An electronic version of this news release may be accessed via our web site at www.amgen.com.